Umit Yasar Selected Research

Cytochrome P-450 CYP2C9

10/2017	Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease.
10/2015	Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
6/2007	Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients.
2/2006	Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.
5/2004	Warfarin resistance with poor CYP2C9 activity and CYP2C912 genotype.
12/2003	Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
4/2002	Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Umit Yasar Research Topics

Disease

3	Neoplasms (Cancer) 04/2015 - 01/2006
3	Colorectal Neoplasms (Colorectal Cancer) 02/2006 - 04/2002
2	Inflammation (Inflammations) 10/2017 - 10/2015
2	Disease Progression 07/2008 - 02/2006
2	Seizures (Absence Seizure) 07/2008 - 07/2008
2	Epilepsy (Aura) 07/2008 - 06/2007
1	Ischemic Stroke 04/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Gastritis 02/2017
1	Peptic Ulcer (Peptic Ulcers) 02/2017
1	Vomiting 04/2015
1	Nausea 04/2015
1	Craniocerebral Trauma (Head Injury) 01/2012
1	Brain Edema (Cerebral Edema) 01/2012
1	Brain Injuries (Brain Injury) 01/2012
1	Wounds and Injuries (Trauma) 01/2012
1	Hyperphosphatemia 07/2008
1	Pseudohypoparathyroidism 07/2008
1	Hypocalcemia 07/2008
1	Vitamin D Deficiency 07/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2007
1	Intracranial Vasospasm 12/2007
1	Familial Mediterranean Fever (Periodic Disease) 07/2007
1	Hypotension (Low Blood Pressure) 01/2007
1	Bradycardia 01/2007
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 02/2006
1	Hyperlipidemias (Hyperlipidemia) 02/2006
1	Hypertriglyceridemia 02/2006
1	Breast Neoplasms (Breast Cancer) 02/2006
1	Hematologic Neoplasms (Hematological Malignancy) 01/2006
1	Coumarin Resistance 05/2004
1	Spasm (Spasms) 01/2004
1	Myocardial Infarction 12/2003

Drug/Important Bio-Agent (IBA)

7	Cytochrome P-450 CYP2C9IBA 10/2017 - 04/2002
5	EnzymesIBA 10/2017 - 04/2002
5	Pharmaceutical PreparationsIBA 10/2017 - 02/2006
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2017 - 02/2006
2	Colchicine FDA LinkGeneric 10/2015 - 07/2007
1	KATP ChannelsIBA 04/2019
1	Pantoprazole (Protonix)FDA LinkGeneric 02/2017
1	Cytochrome P-450 CYP3AIBA 02/2017
1	Cytochrome P-450 CYP2C19IBA 02/2017
1	Proton Pump InhibitorsIBA 02/2017
1	TabletsIBA 02/2017
1	CytokinesIBA 10/2015
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 04/2015
1	AntiemeticsIBA 04/2015
1	CalciumIBA 01/2012
1	MelatoninIBA 01/2012
1	Nimodipine (Modus)FDA LinkGeneric 01/2012
1	hydroxide ionIBA 07/2008
1	Parathyroid Hormone (Parathormone)IBA 07/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2008
1	Uric Acid (Urate)IBA 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 07/2008
1	Raloxifene Hydrochloride (Evista)FDA Link 12/2007
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2007
1	Drug CombinationsIBA 06/2007
1	Losartan (Cozaar)FDA LinkGeneric 06/2007
1	Fluorouracil (Carac)FDA LinkGeneric 02/2006
1	Triglycerides (Triacylglycerol)IBA 02/2006
1	Capecitabine (Xeloda)FDA Link 02/2006
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2006
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2006
1	4-hydroxycyclophosphamideIBA 01/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2006
1	cytochrome P-450 CYP2C subfamilyIBA 01/2004
1	CytochromesIBA 12/2003
1	Cytochrome P-450 CYP2C8IBA 12/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 04/2015